06.12.2005 – 11:03

Marseille-Kliniken AG

euro adhoc: Marseille-Kliniken AG
Financing, Stock Offerings (IPO)
- Another substantial sale-and-leaseback business is concluded - CIT Group purchases 10 portfolio properties in the care and rehabilitation sector for over EUR117m - Significant imp

  Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.

06.12.2005

Berlin, 6th December 2005. Marseille-Kliniken AG (Prime Standard,
ISIN DE 0007783003, MKA) was able to successfully conclude after the
GE deal a second substantial sale-and-leaseback contract with the
properties investor CIT Group Europe, Great Britain. This involves
Marseille-Kliniken AG selling a total of 10 portfolio properties, 8
of which are from the care sector and two from the rehabilitation
sector, with approximately 1,550 beds to the English investor by
means of a sale-and-leaseback agreement, and at the same time renting
them back in the long term.

With a volume of over EUR117m, this transaction sets another new
milestone in the Marseille-Kliniken AG’s strategy of concentrating
primarily on the health facilities business in future, and expanding
their overall bed capacity to 12,000 beds by the year 2008. Once
successfully implemented, the Marseille-Kliniken AG’s property
portfolio will be distributed between approx. 30% facilities of their
own and 70% rented facilities, and will therefore represent a ratio
which the company had set themselves as their target.

With this transaction, Marseille-Kliniken AG are able to pay off
long-term financial debts, it considerably improves their capital
ratio, and it creates further financial scope for the implementation
of their growth strategy.

end of announcement                               euro adhoc 06.12.2005 10:25:38

Further inquiry note:

Marseille-Kliniken AG
Axel Hölzer
CEO
Alte Jakobstraße 79/80
10709 Berlin
Tel.: 030 / 246 32-400
Fax: 030 / 246 32-401

Hillermann Consulting
Christian Hillermann
Investor Relations
Eppendorfer Baum 5
20249 Hamburg
Tel.: 040 / 414 069-13
Fax: 040 / 414 069-14

Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurter Wertpapierbörse / official dealing/prime standard
Berliner Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bremer Wertpapierbörse (BWB) / free trade
Hamburger Wertpapierbörse / official dealing